| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |